Crossmark

Receipt of long-acting injectable antiretroviral therapy among people with HIV in Southern US states: an assessment using electronic health records and claims data

Crossref DOI link: https://doi.org/10.1186/s12981-024-00690-9

Published Online: 2025-02-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Yiyang

Fisk-Hoffman, Rebecca J.

Patel, Maitri

Cook, Robert L.

Prosperi, Mattia
Funding

Funding for this research was provided by:

National Institute of Allergy and Infectious Diseases (R01AI145552, R01AI145552, R01AI145552)

Merck

National Institute on Alcohol Abuse and Alcoholism (F31AA030518, U24AA029959)
License Information

Text and Data Mining valid from 2025-02-01

Version of Record valid from 2025-02-01
More Information

Article History

Received: 26 August 2024

Accepted: 13 December 2024

First Online: 1 February 2025

Declarations

:

: The authors received research funding from Merck via its Investigator-Initiated Studies Program and received travel reimbursement from Merck to present related results at conferences.

Document is current

Any future updates will be listed below